Skip to main content
logo
bioXXmed AG (FRA:T5O)
Germany flag Germany · Delayed Price · Currency is EUR
0.8700
+0.0400 (4.82%)
Last updated: Aug 3, 2026, 11:31 AM CET

bioXXmed AG Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.0200.020.010.04
Revenue Growth
-18.36%378.99%-79.93%42.27%-72.59%23.96%
Gross Profit
0.020.0200.020.010.04
Operating Income
-0.27-0.27-0.87-0.81-0.82-1.57
Net Income
-0.37-0.37-1-20.95-0.83-4.06
Earnings Per Share
-1.34-1.34-3.67-203.88-8.08-50.38
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.20.20.250.611.840
Total Debt
0.390.39-0.01-0.12
Net Cash (Debt)
-0.18-0.180.250.611.84-0.12
Net Cash Growth
---58.08%-67.09%--
Net Cash Per Share
-0.67-0.670.935.8917.91-1.50

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.34-0.34-0.92-0.73-0.91-
Capital Expenditures
-----0-
Free Cash Flow
-0.34-0.34-0.92-0.73-0.91-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1621.11%-1621.11%-24950.87%-4633.08%-6727.67%-3516.49%
Pretax Margin
-2184.46%-2184.46%-28540.14%-120369.63%-6783.59%-9095.43%
Profit Margin
-2183.91%-2183.91%-28540.14%-120369.63%-6783.58%-9095.43%
FCF Margin
-2002.27%-2002.27%-26223.88%-4194.44%-7473.42%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.7214.7214.7214.7214.72
PS Ratio
14.141.79192.67295.19466.16412.49